An evidence-based review of the current treatment of congenital diaphragmatic hernia

Junaid Haroon1, Ronald S Chamberlain

  • 1Saint Barnabas Medical Center, Livingston, NJ 07039, USA.

Clinical Pediatrics
|February 5, 2013
PubMed

Insights

Congenital diaphragmatic hernia (CDH) is a severe condition in newborns. Treatment is shifting towards initial stabilization and delayed surgery, with fetal intervention showing promise for improved lung development and outcomes.

Area of Science:

  • Pediatric Surgery
  • Neonatology
  • Fetal Medicine

Background:

  • Congenital diaphragmatic hernia (CDH) affects 1 in 2000-3000 newborns, with a 67% survival rate.
  • Prenatal diagnosis is common, but treatment has historically focused on immediate postnatal surgical repair.

Purpose of the Study:

  • To review the evolving treatment strategies for CDH.
  • To highlight the benefits of delayed surgical repair and fetal interventions.
  • To address long-term complications and the need for standardized care.

Main Methods:

  • Review of recent literature on CDH management.
  • Discussion of advancements in fetal endoscopic tracheal occlusion (FETO).
  • Analysis of outcomes associated with current therapeutic approaches.

Main Results:

  • Evidence supports initial stabilization and gentle ventilation before surgery, favoring delayed repair.
  • Fetal intervention, such as FETO, aims to improve lung development and reduce postnatal morbidity.
  • Despite advancements, patients face significant long-term complications.

Conclusions:

  • The management of CDH is transitioning towards less invasive, more lung-protective strategies.
  • Standardization of care through international collaboration is crucial for optimizing outcomes in CDH patients.